CAS 1314891-22-9

N-[2-Methyl-2-(2-phenyl-4-oxazolyl)propyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide

CAS : 1314891-22-9

Formule : C₂₃H₁₉F₃N₄O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 456.4172

Ref: IN-DA00A1H2

TMP195

CAS : 1314891-22-9

TMP195

Degré de pureté : ≥98%

Masse moléculaire : 456.42g/mol

Ref: 54-BUP10089

TMP195

CAS : 1314891-22-9

TMP195 (TFMO 2) is a selective class IIa histone deacetylase (HDAC) inhibitor.

Formule : C₂₃H₁₉F₃N₄O₃

Degré de pureté : 98.92% - 99.64%

Couleur et forme : Solid

Masse moléculaire : 456.42

Ref: TM-T3983

TMP 195

CAS : 1314891-22-9

Formule : C₂₃H₁₉F₃N₄O₃

Masse moléculaire : 456.14

Ref: 4Z-K-031134

N-[2-Methyl-2-(2-phenyloxazol-4-yl)propyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]benzaMide

CAS : 1314891-22-9

Degré de pureté : 98%

Masse moléculaire : 456.4249878

Ref: 10-F866438

TMP195

CAS : 1314891-22-9

TMP195 is a small molecule that inhibits the acetylation of histone H3 at lysine 9 (H3K9) and histone H4 at lysine 12 (H4K12). TMP195 has been shown to reduce the growth of metastatic colorectal cancer cells in vivo. It also inhibits tumor growth by decreasing the expression of colony-stimulating factor, which is involved in cell proliferation and differentiation. TMP195 may be used as a therapeutic agent for the treatment of cancers such as breast, lung, prostate, colon, and pancreas.

Formule : C₂₃H₁₉F₃N₄O₃

Degré de pureté : Min. 95%

Masse moléculaire : 456.42 g/mol

Ref: 3D-PCC89122